COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 202 filers reported holding COHERUS BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $416 | -12.8% | 111,336 | -0.3% | 0.00% | 0.0% |
| Q2 2023 | $477 | -35.5% | 111,655 | +3.2% | 0.00% | 0.0% |
| Q1 2023 | $740 | -8.4% | 108,225 | +6.1% | 0.00% | 0.0% |
| Q4 2022 | $808 | -99.9% | 102,041 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $981,000 | -1.0% | 102,041 | -25.5% | 0.00% | 0.0% |
| Q2 2022 | $991,000 | -47.3% | 136,899 | -6.0% | 0.00% | -50.0% |
| Q1 2022 | $1,881,000 | -30.3% | 145,696 | -13.8% | 0.00% | -33.3% |
| Q4 2021 | $2,697,000 | +2.5% | 169,002 | +3.2% | 0.00% | 0.0% |
| Q3 2021 | $2,632,000 | +52.5% | 163,753 | +31.2% | 0.00% | +50.0% |
| Q2 2021 | $1,726,000 | +7.0% | 124,814 | +13.0% | 0.00% | 0.0% |
| Q1 2021 | $1,613,000 | +5.8% | 110,428 | +25.8% | 0.00% | 0.0% |
| Q4 2020 | $1,525,000 | -26.6% | 87,748 | -22.5% | 0.00% | -33.3% |
| Q3 2020 | $2,077,000 | +29.6% | 113,248 | +26.1% | 0.00% | +50.0% |
| Q2 2020 | $1,603,000 | +13.0% | 89,777 | +2.7% | 0.00% | 0.0% |
| Q1 2020 | $1,418,000 | +20.7% | 87,448 | +34.0% | 0.00% | +100.0% |
| Q4 2019 | $1,175,000 | -8.5% | 65,245 | +2.9% | 0.00% | -50.0% |
| Q3 2019 | $1,284,000 | -8.4% | 63,400 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,401,000 | +107.6% | 63,400 | +28.1% | 0.00% | +100.0% |
| Q1 2019 | $675,000 | +50.7% | 49,500 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $448,000 | -47.9% | 49,500 | -5.0% | 0.00% | 0.0% |
| Q3 2018 | $860,000 | +18.0% | 52,100 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $729,000 | +58.8% | 52,100 | +25.5% | 0.00% | 0.0% |
| Q1 2018 | $459,000 | +19.5% | 41,500 | -4.8% | 0.00% | – |
| Q4 2017 | $384,000 | -34.0% | 43,600 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $582,000 | -7.0% | 43,600 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $626,000 | -10.3% | 43,600 | +32.1% | 0.00% | 0.0% |
| Q1 2017 | $698,000 | -25.7% | 33,001 | -1.1% | 0.00% | 0.0% |
| Q4 2016 | $939,000 | +16.1% | 33,370 | +10.5% | 0.00% | 0.0% |
| Q3 2016 | $809,000 | +58.6% | 30,200 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $510,000 | +3.4% | 30,200 | +30.2% | 0.00% | 0.0% |
| Q1 2016 | $493,000 | -7.5% | 23,200 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $533,000 | +14.6% | 23,200 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $465,000 | -7.7% | 23,200 | +33.1% | 0.00% | 0.0% |
| Q2 2015 | $504,000 | – | 17,435 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |